209 related articles for article (PubMed ID: 30930164)
1. Discovery of Covalent CDK14 Inhibitors with Pan-TAIRE Family Specificity.
Ferguson FM; Doctor ZM; Ficarro SB; Browne CM; Marto JA; Johnson JL; Yaron TM; Cantley LC; Kim ND; Sim T; Berberich MJ; Kalocsay M; Sorger PK; Gray NS
Cell Chem Biol; 2019 Jun; 26(6):804-817.e12. PubMed ID: 30930164
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.
Ferguson FM; Doctor ZM; Ficarro SB; Marto JA; Kim ND; Sim T; Gray NS
Bioorg Med Chem Lett; 2019 Aug; 29(15):1985-1993. PubMed ID: 31175010
[TBL] [Abstract][Full Text] [Related]
3. Meriolins, a new class of cell death inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinases.
Bettayeb K; Tirado OM; Marionneau-Lambot S; Ferandin Y; Lozach O; Morris JC; Mateo-Lozano S; Drueckes P; Schächtele C; Kubbutat MH; Liger F; Marquet B; Joseph B; Echalier A; Endicott JA; Notario V; Meijer L
Cancer Res; 2007 Sep; 67(17):8325-34. PubMed ID: 17804748
[TBL] [Abstract][Full Text] [Related]
4. CDK14 Contributes to Reactive Gliosis via Interaction with Cyclin Y in Rat Model of Spinal Cord Injury.
Duan C; Liu Y; Lu L; Cai R; Xue H; Mao X; Chen C; Qian R; Zhang D; Shen A
J Mol Neurosci; 2015 Dec; 57(4):571-9. PubMed ID: 26315607
[TBL] [Abstract][Full Text] [Related]
5. CDK14 inhibition reduces mammary stem cell activity and suppresses triple negative breast cancer progression.
Zhang M; Zhang L; Geng A; Li X; Zhou Y; Xu L; Zeng YA; Li J; Cai C
Cell Rep; 2022 Sep; 40(11):111331. PubMed ID: 36103813
[TBL] [Abstract][Full Text] [Related]
6. Label-Free Bottom-Up Proteomic Workflow for Simultaneously Assessing the Target Specificity of Covalent Drug Candidates and Their Off-Target Reactivity to Selected Proteins.
Yang Y; Shu YZ; Humphreys WG
Chem Res Toxicol; 2016 Jan; 29(1):109-16. PubMed ID: 26675335
[TBL] [Abstract][Full Text] [Related]
7. How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
Jorda R; Hendrychová D; Voller J; Řezníčková E; Gucký T; Kryštof V
J Med Chem; 2018 Oct; 61(20):9105-9120. PubMed ID: 30234987
[TBL] [Abstract][Full Text] [Related]
8. Discovery of hydroxyaniline amides as selective Extracellular Regulated Kinase (Erk) inhibitors.
Zhu HY; Desai J; Deng Y; Cooper A; Wang J; Shipps J; Samatar A; Carr D; Windsor W
Bioorg Med Chem Lett; 2015 Apr; 25(7):1627-9. PubMed ID: 25716905
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure-activity relationship and biological evaluation of 2,4,5-trisubstituted pyrimidine CDK inhibitors as potential anti-tumour agents.
Shao H; Shi S; Foley DW; Lam F; Abbas AY; Liu X; Huang S; Jiang X; Baharin N; Fischer PM; Wang S
Eur J Med Chem; 2013; 70():447-55. PubMed ID: 24185375
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a phenylpyrazole amide ROCK inhibitor as a tool molecule for in vivo studies.
Hu Z; Wang C; Glunz PW; Li J; Cheadle NL; Chen AY; Chen XQ; Myers JE; Guarino VR; Rose A; Sack JS; Sitkoff D; Taylor DS; Xu S; Yan C; Zhang H; Zhang L; Hennan J; Adam LP; Wexler RR; Quan ML
Bioorg Med Chem Lett; 2020 Nov; 30(21):127495. PubMed ID: 32798651
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro biological evaluation of 2,6,9-trisubstituted purines targeting multiple cyclin-dependent kinases.
Zatloukal M; Jorda R; Gucký T; Řezníčková E; Voller J; Pospíšil T; Malínková V; Adamcová H; Kryštof V; Strnad M
Eur J Med Chem; 2013 Mar; 61():61-72. PubMed ID: 22770608
[TBL] [Abstract][Full Text] [Related]
12. The discovery and initial optimisation of pyrrole-2-carboxamides as inhibitors of p38alpha MAP kinase.
Down K; Bamborough P; Alder C; Campbell A; Christopher JA; Gerelle M; Ludbrook S; Mallett D; Mellor G; Miller DD; Pearson R; Ray K; Solanke Y; Somers D
Bioorg Med Chem Lett; 2010 Jul; 20(13):3936-40. PubMed ID: 20570148
[TBL] [Abstract][Full Text] [Related]
13. CDK14 expression is down-regulated by cigarette smoke in vivo and in vitro.
Pollack D; Xiao Y; Shrivasatava V; Levy A; Andrusier M; D'Armiento J; Holz MK; Vigodner M
Toxicol Lett; 2015 Apr; 234(2):120-30. PubMed ID: 25680692
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent biosensors for drug discovery new tools for old targets--screening for inhibitors of cyclin-dependent kinases.
Prével C; Kurzawa L; Van TN; Morris MC
Eur J Med Chem; 2014 Dec; 88():74-88. PubMed ID: 25314935
[TBL] [Abstract][Full Text] [Related]
15. Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides.
Laufer R; Ng G; Liu Y; Patel NK; Edwards LG; Lang Y; Li SW; Feher M; Awrey DE; Leung G; Beletskaya I; Plotnikova O; Mason JM; Hodgson R; Wei X; Mao G; Luo X; Huang P; Green E; Kiarash R; Lin DC; Harris-Brandts M; Ban F; Nadeem V; Mak TW; Pan GJ; Qiu W; Chirgadze NY; Pauls HW
Bioorg Med Chem; 2014 Sep; 22(17):4968-97. PubMed ID: 25043312
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomics of kinase inhibitor targets and mechanisms.
Daub H
ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
[TBL] [Abstract][Full Text] [Related]
17. Selectivity and potency of cyclin-dependent kinase inhibitors.
Sridhar J; Akula N; Pattabiraman N
AAPS J; 2006 Mar; 8(1):E204-21. PubMed ID: 16584130
[TBL] [Abstract][Full Text] [Related]
18. Novel arylazopyrazole inhibitors of cyclin-dependent kinases.
Jorda R; Schütznerová E; Cankař P; Brychtová V; Navrátilová J; Kryštof V
Bioorg Med Chem; 2015 May; 23(9):1975-81. PubMed ID: 25835357
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Optimization of Highly Selective Inhibitors of CDK5.
Daniels MH; Malojcic G; Clugston SL; Williams B; Coeffet-Le Gal M; Pan-Zhou XR; Venkatachalan S; Harmange JC; Ledeboer M
J Med Chem; 2022 Feb; 65(4):3575-3596. PubMed ID: 35143203
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neuronal apoptosis by the cyclin-dependent kinase inhibitor GW8510: identification of 3' substituted indolones as a scaffold for the development of neuroprotective drugs.
Johnson K; Liu L; Majdzadeh N; Chavez C; Chin PC; Morrison B; Wang L; Park J; Chugh P; Chen HM; D'Mello SR
J Neurochem; 2005 May; 93(3):538-48. PubMed ID: 15836613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
